Jemperli achieves sustained clinical complete responses in dMMR/MSI-H locally advanced rectal cancer, phase II study finds

In modern oncology, important insights from clinical trials often emerge years after initial publication. As new therapies extend survival and transition more patients into long-term remissions, clinicians and researchers are increasingly looking beyond initial response rates to understand durability, long-term safety, and even the possibility of a cure.